-
Adlai Nortye Ltd. Announces Closing of Initial Public Offering
03 Oct 2023 16:05 GMT
… closing of its previously announced initial public offering of 2,500,000 American … companies such as Eisai and Novartis, to fully realize the potential … with respect to the proposed initial public offering and the concurrent private placement …
-
Adlai Nortye Ltd. Announces Pricing of Initial Public Offering
29 Sep 2023 06:46 GMT
… announced the pricing of its initial public offering of 2,500,000 American … companies such as Eisai and Novartis, to fully realize the potential … with respect to the proposed initial public offering and the concurrent private placement …
-
Kyverna CEO Peter Maag on courting investors in a ‘volatile’ IPO market
09 Feb 2024 18:07 GMT
…
Still, every spurt of IPO activity during biotech’s recent … other drugmakers, including pharmaceutical giants Novartis and Bristol Myers Squibb.
“ … seeing.’
It seems like IPOs are only possible right now … seen an early uptick in IPO activity this year, though. …
-
Health News Roundup: Gilead-backed Kyverna Therapeutics aims for $857.3 million valuation in upsized IPO; Lilly expects strong 2024 profit on rising demand for weight-loss drug and more
06 Feb 2024 13:02 GMT
… Wegovy and Zepbound, respectively.
Novartis to acquire cancer-focused … $2.9 billion
Drugmaker Novartis AG said it will … Monday that Switzerland-based Novartis was in advanced talks … in its U.S. initial public offering (IPO), the biotechnology company said …
-
Biotech IPOs Jump More Than 20% as Momentum Builds for Listings
08 Feb 2024 01:29 GMT
… much as 22% above its IPO price, Alto Neuroscience Inc. rising … -performing debutants in a choppy IPO market that has seen mixed … as big drug makers like Novartis AG and Bristol Myers Squibb … Sets the Stage for Biotech IPOs
Drug developers have been actively …
-
JPM24: Novartis’ head start, FTC fallout and Bluebird’s price defense
10 Jan 2024 17:21 GMT
… for details.
Radiopharmaceutical rivals chase Novartis
Radiopharmaceuticals, which deliver a … against other targets. Notably, Novartis is also exploring other radioactive … discussing whether to pursue an initial public offering amid recent signs of market …
-
GSK, Novartis, Calliditas among winners at LSX Awards
16 Nov 2023 20:48 GMT
… Health become joint winners with Novartis and Chinook Therapeutics.
In … month, Swiss biopharma giant Novartis announced its plans to … Year – NewAmsterdam Pharma
Post-IPO Raise of the Year – … GSK and Bellus Health and Novartis and Chinook Therapeutics
Pharma …
-
Legend Biotech’s deal with Novartis is a reminder that biotech’s bear market has a few haves, and many have-nots
14 Nov 2023 22:24 GMT
… year treatment already marketed by Novartis. Both medicines target PCSK9, … theory be more powerful than Novartis’, which silences its expression … 90% since that 2021 IPO, left the company with … types. The agreement tasks Novartis with conducting and paying …
-
Novartis Hikes Its Earnings Outlook For The Third Time This Year
24 Oct 2023 15:14 GMT
… Analysts polled by FactSet expected Novartis to earn $1.67 … Sandoz generic drugs business which Novartis recently spun off.
For … a low double-digit percentage. Novartis stock analysts forecasted an adjusted … To Buy And Watch: Top IPOs, Big And Small Caps, …
-
Novartis Hikes Its Earnings Outlook For The Third Time This Year
24 Oct 2023 15:14 GMT
Apellis Pharmaceuticals (APLS) saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 66 to 74.
X
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
This …